Navigation Links
Cogdell Spencer Inc. Announces Increased Earnings in 2008, Cautious Outlook for 2009
Date:2/25/2009

ves FFO is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs, many of which present FFO when reporting their results. FFO is intended to exclude GAAP historical cost depreciation and amortization of real estate and related assets, which assumes that the value of real estate assets diminishes ratably over time. Historically, however, real estate values have risen or fallen with market conditions. Because FFO excludes depreciation and amortization unique to real estate, gains and losses from property dispositions and extraordinary items, it provides a performance measure that, when compared year over year, reflects the impact to operations from trends in occupancy rates, rental rates, operating costs, development activities and interest costs, providing a perspective not immediately apparent from net income. The Company computes FFO in accordance with standards established by the Board of Governors of NAREIT in its March 1995 White Paper (as amended in November 1999 and April 2002), which may differ from the methodology for calculating FFO utilized by other equity REITs and, accordingly, may not be comparable to such other REITs. Further, FFO and FFOM do not represent amounts available for management's discretionary use because of needed capital replacement or expansion, debt service obligations, or other commitments and uncertainties. FFO and FFOM should not be considered as an alternative to net income (loss) (computed in accordance with GAAP) as an indicator of the Company's performance, nor are they indicative of funds available to fund its cash needs, including its ability to pay dividends or make distributions. A reconciliation from GAAP net loss to FFO and FFOM is included as an attachment to this press release.

Conference Call

Cogdell Spencer Inc. invites you to attend the Company's Fourth Quarter 2008 Conference Call on Thursday, February 26, 2009 at 4:00
'/>"/>

SOURCE Cogdell Spencer Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results
3. Cogdell Spencer Announces a $100 Million Development at St. Lukes Riverside Outpatient Campus In Bethlehem, Pennsylvania
4. Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates
5. Cogdell Spencer Inc. Announces the Closing of the Marshall Erdman and Associates Merger
6. Cogdell Spencer Inc. Announces First Quarter Earnings Release and Conference Call Notice
7. Cogdell Spencer Inc. Reports First Quarter 2008 Financial Results
8. Cogdell Spencer Announces First Synergy Project in Pensacola, Florida
9. Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results
10. Cogdell Spencer Inc. Declares Quarterly Dividend and Outlines 2009 Business Strategy
11. Cogdell Memorial Hospital Partners with Healthcare Management Systems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 1Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 2Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 1Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 2Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 1Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 2Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 3Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 4Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 5